Ordering
Available Variants10 mg
CHA.40611-10mg
Price
€126.40
Available – Dispatch in 14 days
50 mg
CHA.40611-50mg
Price
€411.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.40611-10mg | €126.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.40611-50mg | €411.20 |
≥98% (HPLC), nonsteroidal aromatase inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C14H13N3·HCl |
|---|---|
| CAS Number | 102676-31-3 |
| Molecular Weight | 259.73 |
| UNSPSC Code | 51111800 |
| PubChem Substance ID | 329799706 |
| NACRES | NA.77 |
| MDL number | MFCD00866239 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS06
GHS08
  GHS06,GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H301,H361 |
| pcodes | P202 - P264 - P280 - P301 + P310 - P405 - P501 |
| Hazard Classifications | Acute Tox. 3 Oral - Repr. 2 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 2 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
Fadrozole hydrochloride, with a CAS number of 102676-31-3, is a potent aromatase inhibitor that has been utilized in various research and clinical settings. Its primary mechanism of action involves the selective inhibition of the aromatase enzyme, which is responsible for the conversion of androgens to estrogens. By blocking this enzyme, fadrozole hydrochloride effectively reduces estrogen levels in the body, making it a valuable tool in the treatment of estrogen-dependent disorders, such as breast cancer and endometriosis. Additionally, its high specificity and potency have led to its use in various scientific studies, providing valuable insights into the role of estrogen in various physiological and pathological processes. Overall, fadrozole hydrochloride is a significant compound with important applications in both clinical and research settings, particularly in the field of endocrinology and oncology.
